✦ LIBER ✦
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications
✍ Scribed by V. Baldo; T. Baldovin; A. Floreani; A.M. Carraro; R. Trivello
- Book ID
- 116959646
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 284 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.